Pre2 CaP laboratory study reveals important barriers and facilitators of access to PSA screening
Prostate-specific antigen (PSA) screening for prostate cancer remains controversial due to lack of consistent survival benefits reported from clinical trials, and concerns about harms associated with overtreatment. However, it is … Read More